Exclusive Content
Clinical Trial Explores Psychedelic Treatment for Depression
LOS ANGELES- In a move within the field of psychiatric treatment, MindBio Therapeutics Corp. has announced the launch of its Phase 2B clinical trial,...
Indiana’s Pioneering Psilocybin Research Bill Awaits Governor’s Approval
LOS ANGELES- In a groundbreaking legislative move, Indiana stands on the precipice of advancing psilocybin research, following the final approval of a bill aimed...
Cybin Eyes $150 Million Boost Through Private Placement to Propel Psychedelic Drug Development
Cybin Inc., a firm at the forefront of psychedelic drug development, announced its plan on Wednesday to secure approximately $150 million in funding through...
atai Life Sciences Advances VLS-01, A Novel DMT-Based Treatment
LOS ANGELES- atai Life Sciences a biotechnology company specializing in mental health treatments, is making strides in the development of a groundbreaking approach to...
FDA’s ‘Breakthrough’ Nod to MM120, An LSD-Derivative, for Anxiety Relief
LOS ANGELES- In a significant development within the field of psychedelic therapy, the Food and Drug Administration (FDA) has recognized the LSD-analog substance MM120,...
New Mexico Advances Psilocybin Research with Memorial Legislation
-LOS ANGELES- In a significant move toward exploring alternative therapeutic treatments, New Mexico Governor Michelle Lujan Grisham has signed Senate Memorial 12 (SM-12), initiating...
